Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Rescue Strategy for Nonviable Hybridomas: Amplifying Heavy- and Light-Chain Sequences from Genomic DNA by Polymerase Chain Reaction.

Dasch JR, Dasch AL.

Cold Spring Harb Protoc. 2017 Oct 3;2017(10):pdb.prot093880. doi: 10.1101/pdb.prot093880.

PMID:
28974656
2.

Modification of Antibody Function by Mutagenesis.

Dasch JR, Dasch AL.

Cold Spring Harb Protoc. 2017 Sep 1;2017(9):pdb.prot093872. doi: 10.1101/pdb.prot093872.

PMID:
28864569
3.

Using Phage Display to Create Recombinant Antibodies.

Dasch JR, Dasch AL.

Cold Spring Harb Protoc. 2017 Sep 1;2017(9):pdb.prot093864. doi: 10.1101/pdb.prot093864.

PMID:
28864568
4.

Creation of Recombinant Antibodies: Using 5'-RACE to Amplify Immunoglobulin Sequences.

Dasch JR, Dasch AL.

Cold Spring Harb Protoc. 2017 Aug 1;2017(8):pdb.prot093856. doi: 10.1101/pdb.prot093856.

PMID:
28765299
5.

Creation of Recombinant Antibodies: Using Degenerate Oligonucleotides to Amplify Heavy- and Light-Chain Sequences.

Dasch JR, Dasch AL.

Cold Spring Harb Protoc. 2017 Aug 1;2017(8):pdb.prot093849. doi: 10.1101/pdb.prot093849.

PMID:
28765298
6.

Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis.

Porat R, Paddock HN, Schwaitzberg SD, Connolly RJ, Wilkens T, Dasch JR, Gascon MP, Hutchison JS, Ythier A, Wallach D, et al.

Crit Care Med. 1995 Jun;23(6):1080-9.

PMID:
7774220
7.
8.

Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-beta.

Waegell WO, Higley HR, Kincade PW, Dasch JR.

Exp Hematol. 1994 Oct;22(11):1051-7.

PMID:
7925771
9.

Interleukin 10 inhibits transforming growth factor-beta (TGF-beta) synthesis required for osteogenic commitment of mouse bone marrow cells.

Van Vlasselaer P, Borremans B, van Gorp U, Dasch JR, De Waal-Malefyt R.

J Cell Biol. 1994 Feb;124(4):569-77.

10.

Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro.

Snapper CM, Waegell W, Beernink H, Dasch JR.

J Immunol. 1993 Nov 1;151(9):4625-36.

PMID:
8409423
11.

Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon.

Gabrielli A, Di Loreto C, Taborro R, Candela M, Sambo P, Nitti C, Danieli MG, DeLustro F, Dasch JR, Danieli G.

Clin Immunol Immunopathol. 1993 Sep;68(3):340-9.

PMID:
8370185
12.

Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells.

McIntyre TM, Klinman DR, Rothman P, Lugo M, Dasch JR, Mond JJ, Snapper CM.

J Exp Med. 1993 Apr 1;177(4):1031-7.

13.

Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta.

Wahl SM, Allen JB, Costa GL, Wong HL, Dasch JR.

J Exp Med. 1993 Jan 1;177(1):225-30.

14.

Characterization of monoclonal antibodies recognizing bovine bone osteoglycin.

Dasch JR, Pace DR, Avis PD, Bentz H, Chu S.

Connect Tissue Res. 1993;30(1):11-21.

PMID:
7512011
15.

Regulation of synovial cell growth. Coexpression of transforming growth factor beta and basic fibroblast growth factor by cultured synovial cells.

Goddard DH, Grossman SL, Williams WV, Weiner DB, Gross JL, Eidsvoog K, Dasch JR.

Arthritis Rheum. 1992 Nov;35(11):1296-303.

PMID:
1445445
16.

Skin distribution and differential expression of transforming growth factor beta 1 and beta 2.

Falanga V, Gerhardt CO, Dasch JR, Takehara K, Ksander GA.

J Dermatol Sci. 1992 May;3(3):131-6.

PMID:
1498091
17.

Purification and characterization of transforming growth factor-beta 2.3 and -beta 1.2 heterodimers from bovine bone.

Ogawa Y, Schmidt DK, Dasch JR, Chang RJ, Glaser CB.

J Biol Chem. 1992 Feb 5;267(4):2325-8.

19.

IGG-stimulated and LPS-stimulated monocytes elaborate transforming growth factor type beta (TGF-beta) in active form.

Schalch L, Rordorf-Adam C, Dasch JR, Jungi TW.

Biochem Biophys Res Commun. 1991 Jan 31;174(2):885-91.

PMID:
1993079
20.

A novel polyclonal antibody (CL-B1/29) for immunolocalization of transforming growth factor-beta 2 (TGF-beta 2) in adult mouse.

Ksander GA, Gerhardt CO, Dasch JR, Ellingsworth LR.

J Histochem Cytochem. 1990 Dec;38(12):1831-40.

PMID:
2254647
21.

Purification and characterization of a unique osteoinductive factor from bovine bone.

Bentz H, Nathan RM, Rosen DM, Armstrong RM, Thompson AY, Segarini PR, Mathews MC, Dasch JR, Piez KA, Seyedin SM.

J Biol Chem. 1989 Dec 5;264(34):20805-10.

22.
23.
24.

Mitogen-induced phosphorylation of cytosolic proteins in rabbit T- and B-lymphocytes.

Dasch JR, Stavitsky AB.

Mol Immunol. 1985 Apr;22(4):379-89.

PMID:
3875784
25.

Effects of trifluoperazine, a calmodulin antagonist, on rabbit T- and B-cell responses to mitogens and antigen.

Stavitsky AB, Dasch JR, Astrachan L.

Cell Immunol. 1984 Sep;87(2):411-23.

PMID:
6331894
26.

Anti-immunoglobulin-induced proliferative response of rabbit lymphocytes in a serum-free medium.

Dasch JR, Stavitsky AB.

J Immunol Methods. 1983 Apr 29;59(2):167-82.

PMID:
6601677

Supplemental Content

Loading ...
Support Center